Tech Company Financing Transactions
Seaside Therapeutics Funding Round
Seaside Therapeutics, based in Cambridge, raised $30 million from private investors.
Transaction Overview
Company Name
Announced On
9/17/2009
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The financing will be used to fund the Company's pipeline of novel therapeutic candidates to correct or improve the course of those who suffer these disorders.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
840 Memorial Drive
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Seaside founders understand the toll that brain development disorders, including autism and mental retardation, take on families.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Randall Carpenter
VP - R & D
Aileen Healy
VP - Regulatory Affairs
John Weet
Browse more venture capital transactions:
Prev: 9/17/2009: Calypso Medical Technologies venture capital transaction
Next: 9/17/2009: CriticalMix venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs